IL89049A0 - Pharmaceutical composition containing 4-aroylimidazol-2-ones - Google Patents

Pharmaceutical composition containing 4-aroylimidazol-2-ones

Info

Publication number
IL89049A0
IL89049A0 IL89049A IL8904989A IL89049A0 IL 89049 A0 IL89049 A0 IL 89049A0 IL 89049 A IL89049 A IL 89049A IL 8904989 A IL8904989 A IL 8904989A IL 89049 A0 IL89049 A0 IL 89049A0
Authority
IL
Israel
Prior art keywords
aroylimidazol
ones
pharmaceutical composition
composition containing
pharmaceutical
Prior art date
Application number
IL89049A
Other languages
English (en)
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL89049A0 publication Critical patent/IL89049A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL89049A 1988-01-29 1989-01-24 Pharmaceutical composition containing 4-aroylimidazol-2-ones IL89049A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14980388A 1988-01-29 1988-01-29

Publications (1)

Publication Number Publication Date
IL89049A0 true IL89049A0 (en) 1989-08-15

Family

ID=22531858

Family Applications (1)

Application Number Title Priority Date Filing Date
IL89049A IL89049A0 (en) 1988-01-29 1989-01-24 Pharmaceutical composition containing 4-aroylimidazol-2-ones

Country Status (17)

Country Link
EP (1) EP0326103B1 (xx)
JP (1) JPH01226817A (xx)
KR (1) KR890011594A (xx)
CN (1) CN1035242A (xx)
AR (1) AR241632A1 (xx)
AT (1) ATE78161T1 (xx)
AU (1) AU611757B2 (xx)
DE (1) DE68902056T2 (xx)
DK (1) DK169566B1 (xx)
ES (1) ES2051898T3 (xx)
GR (1) GR3005792T3 (xx)
HU (1) HUT49282A (xx)
IE (1) IE62426B1 (xx)
IL (1) IL89049A0 (xx)
NZ (1) NZ227700A (xx)
PT (1) PT89561B (xx)
ZA (1) ZA89552B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2038744C (en) * 1990-03-23 2002-01-08 Yoshitomi Pharmaceutical Industries Ltd. Pharmaceutical composition containing slightly water-soluble drug
WO2005058280A2 (en) * 2003-12-12 2005-06-30 Myogen, Inc. Enoximone formulations and their use in the treatment of cardiac hypertrophy and heart failure
WO2006007213A1 (en) * 2004-06-23 2006-01-19 Myogen, Inc. Enoximone formulations and their use in the treatment of pde-iii mediated diseases
EP2581082B1 (de) 2011-10-10 2015-12-30 Carinopharm GmbH Pharmazeutische Zusammensetzung zur Behandlung von Status asthmaticus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405635A (en) * 1979-06-18 1983-09-20 Merrell Dow Pharmaceuticals Inc. 4-Aroylimidazol-2-ones and their use as pharmaceuticals
EP0031603A1 (en) * 1979-12-31 1981-07-08 American Cyanamid Company Pharmaceutical composition of matter
OA06863A (fr) * 1980-08-04 1983-02-28 Merck & Co Inc Solubilisation de l'invermectine dans l'eau.
DE3307422A1 (de) * 1983-03-03 1984-09-06 Bayer Ag, 5090 Leverkusen Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs

Also Published As

Publication number Publication date
EP0326103B1 (en) 1992-07-15
DK37589D0 (da) 1989-01-27
NZ227700A (en) 1990-09-26
IE890275L (en) 1989-07-29
DK37589A (da) 1989-07-30
AU611757B2 (en) 1991-06-20
CN1035242A (zh) 1989-09-06
IE62426B1 (en) 1995-02-08
PT89561A (pt) 1989-10-04
HUT49282A (en) 1989-09-28
EP0326103A1 (en) 1989-08-02
GR3005792T3 (xx) 1993-06-07
DK169566B1 (da) 1994-12-05
DE68902056D1 (de) 1992-08-20
JPH01226817A (ja) 1989-09-11
ATE78161T1 (de) 1992-08-15
PT89561B (pt) 1994-01-31
ZA89552B (en) 1989-10-25
KR890011594A (ko) 1989-08-21
ES2051898T3 (es) 1994-07-01
DE68902056T2 (de) 1992-12-03
AR241632A1 (es) 1992-10-30
AU2876889A (en) 1989-08-03

Similar Documents

Publication Publication Date Title
IL90067A0 (en) 1alpha-hydroxyvitamin-d compounds and pharmaceutical compositions containing them
GB2222772B (en) Pharmaceutical compositions
GB2219940B (en) Pharmaceutical compositions
ZA894344B (en) Stable pharmaceutical composition
GB8825892D0 (en) Pharmaceutical composition
HU896876D0 (en) Pharmaceutical compositions
ZA893422B (en) Pharmaceutical composition
EP0443027A4 (en) Drug composition
IL89049A0 (en) Pharmaceutical composition containing 4-aroylimidazol-2-ones
IL91350A0 (en) Phenylalkylthiophenes and related compounds and pharmaceutical compositions containing them
GB2217202B (en) Trimelamol-containing pharmaceutical compositions
GB8830406D0 (en) Pharmaceutical compositions
GB8802926D0 (en) Pharmaceutical composition
GB8818118D0 (en) Pharmaceutical composition
GB8806495D0 (en) Pharmaceutical composition
GB8809849D0 (en) Pharmaceutical composition
GB8807384D0 (en) Pharmaceutical composition
GB8827718D0 (en) Pharmaceutical composition
GB8802927D0 (en) Pharmaceutical composition
GB8818098D0 (en) Pharmaceutical composition
GB8808830D0 (en) Pharmaceutical compositions
ZA893224B (en) Pharmaceutical compositions
GB8809650D0 (en) Pharmaceutical compositions
GB8822507D0 (en) Pharmaceutical compositions
GB8820265D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)

Owner name: AVENTIS INC.

Free format text: FORMER NAME:MERRELL PHARMACEUTICALS INC.